Pancreas transplantation: Indications and consequences

Endocrine Reviews

Volumn 25, Issue 6, 2004, Pages 919-946

  Larsen, Jennifer L ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b 983020 Nebraska Medical Center ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; C PEPTIDE; CORTICOSTEROID; CYCLOSPORIN; GLUCAGON; GLUCOSE; IMMUNOSUPPRESSIVE AGENT; INSULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PROINSULIN; RAPAMYCIN; TACROLIMUS;

BONE MASS; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DYSLIPIDEMIA; GLUCAGON RELEASE; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPOGLYCEMIA; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INSULIN RELEASE; KIDNEY TRANSPLANTATION; MICROANGIOPATHY; OSTEOLYSIS; OSTEOPOROSIS; PANCREAS TRANSPLANTATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; RISK FACTOR; ROUX Y ANASTOMOSIS; SIDE EFFECT; SURGICAL TECHNIQUE; SURVIVAL TIME; TREATMENT INDICATION; TREATMENT OUTCOME; WEIGHT GAIN;

DIABETES MELLITUS; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; FEMALE; HUMANS; HYPOGLYCEMIA; IMMUNOSUPPRESSION; ISLETS OF LANGERHANS; KIDNEY TRANSPLANTATION; MALE; PANCREAS TRANSPLANTATION; PATIENT SELECTION; PREGNANCY; QUALITY OF LIFE; SURVIVAL RATE;

EID: 10644270851     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/er.2002-0036     Document Type: Review

References (305)

1. Kelly WD, Lillehei RC, Merkel FK, Idezuki Y, Goetz F 1967 Allotransplantation of the pancreas and duodenum along with the kidney in diabetic nephropathy. Surgery 61:827-837
2. Gruessner AC, Sutherland DE 2002 Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of October 2002. Clin Transpl 41-77
3. Collins AJ, Kasiske B, Herzog C, Chen SC, Everson S, Constantini E, Grimm R, McBean M, Xue J, Chavers B, Matas A, Manning W, Louis T, Pan W, Liu J, Li S, Roberts T, Dalleska F, Snyder J, Ebben J, Frazier E, Sheets D, Johnson R, Li S, Dunning S, Berrini D, Gno H, Solid C, Arko C, Daniels F, Wang X, Forrest B, Gilbertson D, St Peter W, Frederick P, Eggers P, Agodoa L 2003 Excerpts from the United States Renal Data System 2003 Annual Data Report: atlas of end-stage renal disease in the United States. Am J Kidney Dis 42:A5-A7
4. Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, Held PJ, Port FK 1999 Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 341:1725-1730
5. Ojo A, Wolfe RA, Agodoa LY, Held PJ, Port FK, Leavey SF, Callard SE, Dickinson DM, Schmouder RL, Leichtman AB 1998 Prognosis after primary renal transplant failure and the beneficial effects of repeat transplantation: multivariate analyses from the United States Renal Data System. Transplantation 66:1651-1659
6. Meier-Kriesche HU, Port FK, Ojo AO, Rudich SM, Hanson JA, Cibrik DM, Leichtman AB, Kaplan B 2000 Effect of waiting time on renal transplant outcome. Kidney Int 58:1311-1317
7. Mange KC, Joffe MM, Feldman HI 2001 Effect of the use or nonuse of long-term dialysis on the subsequent survival of renal transplants from living donors. N Engl J Med 344:726-731
8. Kasiske BL, Vazquez MA, Harmon WE, Brown RS, Danovitch GM, Gaston RS, Roth D, Scandling JD, Singer GG 2000 Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol 11(Suppl 15):S1-S86
9. Drachenberg CB, Papadimitriou JC, Farney A, Wiland A, Blahut S, Fink JC, Philosophe B, Schweitzer E, Lal T, Anderson L, Bartlett ST 2001 Pancreas transplantation: the histologic morphology of graft loss and clinical correlations. Transplantation 71:1784-1791
10. Humar A, Gruessner RW, Sutherland DE 1997 Living related donor pancreas and pancreas-kidney transplantation. Br Med Bull 53:879-891
11. Robertson RP, Lanz K, Sutherland D, Seaquist E 2002 Relationship between diabetes and obesity 9 to 18 years after hemipancreatectomy and transplantation in donors and recipients. Transplantation 73:736-741
12. Kendall DM, Sutherland DE, Najarian JS, Goetz FC, Robertson RP 1990 Effects of hemipancreatectomy on insulin secretion and glucose tolerance in healthy humans. N Engl J Med 322:898-903
13. Gruessner R, Sutherland D 1996 Simultaneous kidney and segmental pancreas transplants from living related donors - the first two successful cases. Transplantation 61:1265-1268
14. Zielinski A, Nazarewski S, Bogetti D, Sileri P, Testa G, Sankary H, Benedetti E 2003 Simultaneous pancreas-kidney transplant from living related donor: a single-center experience. Transplantation 76:547-552
15. Zhang L, Krzentowski G, Albert A, Lefebvre PJ 2003 Factors predictive of nephropathy in DCCT Type 1 diabetic patients with good or poor metabolic control. Diabet Med 20:580-585
16. Jacobsen P, Rossing K, Tarnow L, Rossing P, Mallet C, Poirier O, Cambien F, Parving HH 1999 Progression of diabetic nephropathy in normotensive type 1 diabetic patients. Kidney Int (Suppl)71:S101-S105
17. Gruessner A, Sutherland D 2001 Analysis of United States (US) and Non-US Pancreas Transplants Reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of October 2001. In: Cecka J, Terasaki E, eds. Clinical transplants 2001. Los Angeles: UCLA Immunogenetics Center; 41-72
18. Sarnak MJ, Poindexter A, Wang SR, Beck GJ, Kusek JW, Marcovina SM, Greene T, Levey AS 2002 Serum C-reactive protein and leptin as predictors of kidney disease progression in the Modification of Diet in Renal Disease Study. Kidney Int 62:2208-2215
19. De Santo NG, Cirillo M, Perna A, De Santo LS, Anastasio P, Pollastro MR, De Santo RM, Iorio L, Cotrufo M, Rossi F 2001 The heart in uremia: role of hypertension, hypotension, and sleep apnea. Am J Kidney Dis 38:S38-S46
20. Lowbeer C, Stenvinkel P, Pecoits-Filho R, Heimburger O, Lindholm B, Gustafsson SA, Seeberger A 2003 Elevated cardiac troponin T in predialysis patients is associated with inflammation and predicts mortality. J Intern Med 253:153-160
21. Ichihara A, Hayashi M, Ryuzaki M, Handa M, Furukawa T, Saruta T 2002 Fluvastatin prevents development of arterial stiffness in haemodialysis patients with type 2 diabetes mellitus. Nephrol Dial Transplant 17:1513-1517
22. Vlassara H 1994 Serum advanced glycosylation end products: a new class of uremic toxins? Blood Purif 12:54-59
23. Larsen JL, Lynch T, Al-Halawani M, Miller SA, Cushing KA, Baxter BT, Stratta RJ 1995 Carotid intima-media thickness by ultrasound measurement in pancreas transplant candidates. Transplant Proc 27:2996
24. Farney A, Cho E, Schweitzer E, Dunkin B, Philosophe B, Colonna J, Jacobs S, Jarrell B, Flowers JL, Bartlett ST 2000 Simultaneous cadaver pancreas living-donor kidney transplantation: a new approach for the type 1 diabetic uremic patient. Ann Surg 232:696-703
25. Secchi A, Carlo VD, Pozza G 1994 Pancreas transplantation. Lancet 343:607-608 (Letter to the editor)
26. Cecka JM 2000 The UNOS Scientific Renal Transplant Registry - 2000. Clin Transpl 1-18
27. Venstrom JM, McBride MA, Rother KI, Hirshberg B, Orchard TJ, Harlan DM 2003 Survival after pancreas transplantation in patients with diabetes and preserved kidney function. JAMA 290:2817-2823
28. Colling C, Stevens R, Lyden E, Lane J, Mack-Shipman L, Wrenshall L, Larsen J 2004 Greater early pancreas graft loss in women compared to men after simultaneous pancreas-kidney transplantation. Clin Transplant, in press
29. Gjerston D 1995 Multifactorial analysis of renal transplants reported to the United Network for Organ Sharing Registry: a 1994 update. In: Terasaki P, Cecka J, eds. Clinical transplants 1994. Los Angeles: UCLA Tissue Typing Laboratory; 519-539
30. Douzdjian V, Bhaskar S, Baliga P, Gugliuzza K, Rajagopalan P 1997 Effect of race on outcome after kidney and kidney-pancreas transplantation in type 1 diabetic patients. Diabetes Care 20:1310-1314
31. Light J, Sasaki T, Currier C, Barhyte D 2001 Successful long-term kidney-pancreas transplants regardless of C-peptide status or race. Transplantation 71:152-154
32. Gaston RS, Alveranga DY, Becker BN, Distant DA, Held PJ, Bragg-Gresham JL, Humar A, Ting A, Wynn JJ, Leichtman AB 2003 Kidney and pancreas transplantation. Am J Transplant 3(Suppl 4):64-77
33. Gruessner A, Sutherland D 2000 Pancreas transplant outcomes for United States (US) cases reported to the United Network for Organ Sharing (UNOS) and non-US cases reported to the International Pancreas Transplant Registry (IPTR) as of October, 2000. In: Terasaki CA, ed. Clinical transplants 2000. Los Angeles: UCLA Immunogenetics Center; 45-72
34. Humar A, Ramcharan T, Kandaswamy R, Matas A, Gruessner RW, Gruessner AC, Sutherland DE 2001 Pancreas after kidney transplants. Am J Surg 182:155-161
35. American Diabetes Association 2000 Pancreas transplantation for patients with type 1 diabetes. Diabetes Care 23:117
36. Brennan DC, Stratta RJ, Lowell JA, Miller SA, Taylor RJ 1994 Cyclosporine challenge in the decision of combined kidney-pancreas versus solitary pancreas transplantation. Transplantation 57:1606-1611
37. Lane JT, Ratanasuwan T, Mack-Shipman R, Taylor RJ, Leone JP, Miller SA, Lyden ER, Larsen JL 2001 Cyclosporine challenge test revisited: does it predict outcome after solitary pancreas transplantation? Clin Transplant 15:28-31
38. Fioretto P, Steffes MW, Sutherland DE, Goetz FC, Mauer M 1998 Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 339:69-75
39. Sollinger HW, Stratta RJ, D'Alessandro AM, Kalayoglu M, Pirsch JD, Belzer FO 1988 Experience with simultaneous pancreas-kidney transplantation. Ann Surg 208:475-483
40. Corry RJ, Nghiem DD, Schulak JA, Beutel WD, Gonwa TA 1986 Surgical treatment of diabetic nephropathy with simultaneous pancreaticoduodenal and renal transplantation. Surg Gynecol Obstet 162:547-555
41. Schang T, Timmermann W, Thiede A, Najarian JS, Sutherland DE 1991 Detrimental effects of fluid and electrolyte loss from duodenum in bladder-drained pancreas transplants. Transplant Proc 23:1617-1618
42. Del Pizzo J, Jacobs S, Bartlett S, Sklar G 1998 Urological complications of bladder-drained pancreatic allografts. Br J Urol 81:543-547
43. Hickey DP, Bakthavatsalam R, Bannon CA, O'Malley K, Corr J, Little DM 1997 Urological complications of pancreatic transplantation. J Urol 157:2042-2048
44. Larsen J, Ratanasuwan T, Burkman T, Colling C, Lynch T, Erickson J, Lyden E, Miller S, Lane J, Mack-Shipman L 2004 Pancreas transplantation improves vascular disease in patients with type 1 diabetes. Diabetes Care 27:1706-1711
45. Orsenigo E, Cristallo M, Socci C, Castoldi R, Secchi A, Colombo R, Invernizzi L, Fiorina P, Naspro R, Di Carlo V 2002 Urological complications after simultaneous renal and pancreatic transplantation. Eur J Surg 168:609-613
46. Stephanian E, Gruessner RW, Brayman KL, Gores P, Dunn DL, Najarian JS, Sutherland DE 1992 Conversion of exocrine secretions from bladder to enteric drainage in recipients of whole pancreaticoduodenal transplants. Ann Surg 216:663-672
47. Sindhi R, Stratta R, Taylor R 1995 Experience with enteric conversion after pancreas transplantation with bladder drainage. Transplant Proc 27:3014-3015
48. Sindhi R, Stratta RJ, Lowell JA, Sudan D, Cushing KA, Castaldo P, Jervis JT 1997 Experience with enteric conversion after pancreatic transplantation with bladder drainage. J Am Coll Surg 184:281-289
49. Robertson RP, Abid M, Sutherland DE, Diem P 1989 Glucose homeostasis and insulin secretion in human recipients of pancreas transplantation. Diabetes 38(Suppl 1):97-98
50. Diem P, Abid M, Redmon JB, Sutherland DE, Robertson RP 1990 Systemic venous drainage of pancreas allografts as independent cause of hyperinsulinemia in type I diabetic recipients. Diabetes 39:534-540
51. Stratta RJ, Taylor RJ, Zorn BH, Ozaki C, Larsen JL, Duckworth WC, Langnas AN, Wood RP, Wahl TO, Marujo WC, Li S, Shaw Jr BW 1991 Combined pancreas-kidney transplantation: preliminary results and metabolic effects. Am J Gastroenterol 86:697-703
52. Gaber AO, Shokouh-Amiri MH, Hathaway DK, Hammontree L, Kitabchi AE, Gaber LW, Saad MF, Britt LG 1995 Results of pancreas transplantation with portal venous and enteric drainage. Ann Surg 221:613-622; discussion 622-624
53. Bagdade JD, Ritter MC, Kitabchi AE, Huss E, Thistlethwaite R, Gabfr O, Lambeth H 1996 Differing effects of pancreas-kidney transplantation with systemic versus portal venous drainage on cholesteryl ester transfer in IDDM subjects. Diabetes Care 19:1108-1112
54. Stratta R, Gaber O, Shoukouh-Amiri MH, Reddy KS, Egidi MF, Grewal HP, Gaber LW 2000 A prospective comparison of systemic-bladder versus portal-enteric drainage in vascularized pancreas transplantation. Surgery 127:217-226
55. Rosenlof L, Earnhardt R, Pruett T, Stevenson WC, Douglas MT, Cornett GC, Hanks JB 1992 Pancreas transplantation: an initial experience with systemic and portal drainage of pancreatic allografts. Ann Surg 215:586-595
56. Philosophe B, Farney A, Schweitzer E, Colonna JA, Jarrell BE, Krishnamurthi V, Wiland AM, Bartlett ST 2001 Superiority of portal venous drainage over systemic venous drainage in pancreas transplantation. Ann Surg 234:689-696
57. Petruzzo P, Da Silva M, Feitosa LC, Dawahra M, Lefrancois N, Dubernard JM, Martin X 2000 Simultaneous pancreas-kidney transplantation: portal versus systemic venous drainage of the pancreas allografts. Clin Transplant 14:287-291
58. Katz HH, Nguyen TT, Velosa JA, Robertson RP, Rizza RA 1994 Effects of systemic delivery of insulin on plasma lipids and lipoprotein concentrations in pancreas transplant recipients. Mayo Clin Proc 69:231-236
59. Lo A, Stratta RJ, Hathaway DK, Egidi MF, Shokouh-Amiri MH, Grewal HP, Winsett R, Trofe J, Alloway RR, Gaber AO 2001 Long-term outcomes in simultaneous kidney-pancreas transplant recipients with portal-enteric versus systemic-bladder drainage. Am J Kidney Dis 38:132-143
60. Hughes TA, Gaber AO, Amiri HS, Wang X, Elmer DS, Winsett RP, Hathaway DK, Hughes SM 1995 Kidney-pancreas transplantation. The effect of portal versus systemic venous drainage of the pancreas on the lipoprotein composition. Transplantation 601:1406-1412
61. Carpentier A, Patterson B, Uffelman KD, Giacca A, Vranic M, Cattral MS, Lewis GF 2001 The effect of systemic versus portal insulin delivery in pancreas transplantation on insulin action and VLDL metabolism. Diabetes 50:14102-11413
62. Foger B, Konigsrainer A, Palos G, Ritsch A, Trobinger G, Menzel HJ, Lechleitner M, Doblinger A, Konig P, Utermann G, Margreiter R, Patsch JR 1996 Effects of pancreas transplantation on distribution and composition of plasma lipoproteins. Metabolism 45:856-861
63. Zavaroni I, Bonora E, Pagliara M, Dall'Aglio E, Luchetti L, Buonanno G, Bonati PA, Bergonzani M, Gnudi L, Passeri M, Reaven G 1989 Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med 320:702-706
64. Larsen J, Ratanasuwan T, Burkman T, Lynch T, Erickson J, Colling C, Lane J, Mack-Shipman L, Lyden E, Loseke M, Miller S, Leone J 2002 Carotid intima media thickness is decreased after pancreas transplantation. Transplantation 73:936-940
65. Jukema J, Smets Y, van der Pijl J, Zwinderman AH, Vliegen HW, Ringers J, Reiber JH, Lemkes HH, van der Wall EE, de Fijter JW 2001 Impact of simultaneous pancreas and kidney transplantation on progression of coronary atherosclerosis in patients with end stage renal failure due to type I diabetes. Diabetes Care 25:906-911
66. Kaufman DB, Leventhal JR, Stuart J, Abecassis MM, Fryer JP, Stuart FP 1999 Mycophenolate mofetil and tacrolimus as primary maintenance immunosuppression in simultaneous pancreas-kidney transplantation: initial experience in 50 consecutive cases. Transplantation 67:586-593
67. Oh JM, Wiland AM, Klassen DK, Weidle PJ, Bartlett ST 2001 Comparison of azathioprine and mycophenolate mofetil for the prevention of acute rejection in recipients of pancreas transplantation. J Clin Pharmacol 41:861-869
68. Neto A, Haapalainen E, Ferreira R, Feo CF, Misiako EP, Vennarecci G, Porcu A, Dib SA, Goldenberg S, Gomes PO, Nigro AT 1999 Metabolic and ultrastructural effects of cyclosporin A on pancreatic islets. Transpl Int 12:208-212
69. Drachenberg C, Klassen D, Weir M, Wiland A, Fink JC, Bartlett ST, Cangro CB, Blahut S, Papadimitriou JC 1999 Islet cell damage associated with tacrolimus and cyclosporine: morphological features in pancreas allograft biopsies and clinical correlation. Transplantation 68:396-402
70. Tyden G, Bolinder J, Solders G, Brattstrom C, Tibell A, Groth CG 1999 Improved survival in patients with insulin-dependent diabetes mellitus and end-stage diabetic nephropathy 10 years after combined pancreas and kidney transplantation. Transplantation 67:645-648
71. La Rocca E, Fiorina P, Astorri E, Rossitti C, Lucignani G, Fazio Fgiudici D, Castoldi R, Bianchi G, Di Carlo V, Pozza G, Secchi A 2000 Patient survival and cardiovascular events after kidney-pancreas transplantation: comparison with kidney transplnatation alone in uremic IDDM patients. Cell Transplant 9:929-932
72. La Rocca E, Fiorina P, di Carlo V, Astorri E, Rossetti C, Lucignani G, Fazio F, Giudici D, Cristallo M, Bianchi G, Pozza G, Secchi A 2001 Cardiovascular outcomes after kidney-pancreas and kidney-alone transplantation. Kidney Int 60:1964-1971
73. Reddy KS, Stablein D, Taranto S, Stratta RJ, Johnston TD, Waid TH, McKeown JW, Lucas BA, Ranjan D 2003 Long-term survival following simultaneous kidney-pancreas transplantation versus kidney transplantation alone in patients with type 1 diabetes mellitus and renal failure. Am J Kidney Dis 41:464-470
74. Navarro X, Kennedy WR, Aeppli D, Sutherland DE 1996 Neuropathy and mortality in diabetes: influence of pancreas transplantation. Muscle Nerve 19:1009-1016
75. Ojo AO, Meier-Kriesche HU, Hanson JA, Leichtman A, Magee JC, Cibrik D, Wolfe RA, Port FK, Agodoa L, Kaufman DB, Kaplan B 2001 The impact of simultaneous pancreas-kidney transplantation on long-term patient survival. Transplantation 71:82-90
76. Navarro X, Kennedy WR, Sutherland DE 1991 Autonomic neuropathy and survival in diabetes mellitus: effects of pancreas transplantation. Diabetologia 34(Suppl 1):S108-S112
77. Navarro X, Kennedy WR, Loewenson RB, Sutherland DER 1990 Influence of pancreas transplantation on cardiorespiratory reflexes, nerve conduction and mortality in diabetes mellitus. Diabetes 39:802-806
78. Bunnapradist S, Cho YW, Cecka JM, Wilkinson A, Danovitch GM 2003 Kidney allograft and patient survival in type I diabetic recipients of cadaveric kidney alone versus simultaneous pancreas kidney transplants: a multivariate analysis of the UNOS database. J Am Soc Nephrol 14:208-213
79. Rayhill SC, D'Alessandro AM, Odorico JS, Knechtle SJ, Pirsch JD, Heisey DM, Kirk AD, Van der Werf W, Sollinger HW 2000 Simultaneous pancreas-kidney transplantation and living related donor renal transplantation in patients with diabetes: is there a difference in survival? Ann Surg 231:417-423
80. Osei K, Henry ML, O'Dorisio TM, Tesi RJ, Sommer BG, Ferguson RM 1990 Physiological and pharmacological stimulation of pancreatic islet hormone secretion in type I diabetic pancreas allograft recipients. Diabetes 39:1235-1242
81. Katz H, Homan M, Velosa J, Robertson P, Rizza R 1991 Effects of pancreas transplantation on postprandial glucose metabolism. N Engl J Med 325:1278-1283
82. Tran M, Larsen JL, Duckworth WC, Ruby EI, Miller SA, Frisbie K, Taylor K, Taylor RJ, Stratta RJ 1994 Anti-insulin antibodies are a cause of hypoglycemia following pancreas transplantation. Diabetes Care 17:988-993
83. Larsen JL, Stratta RJ, Miller SA, Hirst K, Ozaki C, Taylor RJ, Duckworth WC 1993 Evidence that fasting hyperproinsulinemia after combined pancreas-kidney transplantation diminishes over time. Transplantation 56:1533-1537
84. Kissler HJ, Gepp H, Tannapfel A, Schwille PO 2000 Effect of venous drainage site on insulin action after pancreas transplantation in the rat - is there insulin resistance and a risk for atherosclerosis? Metabolism 49:458-466
85. Blackman JD, Polonsky KS, Jaspan JB, Sturis J, Van Cauter E, Thistlethwaite JR 1992 Insulin secretory profiles and C-peptide clearance kinetics at 6 months and 2 years after kidney-pancreas transplantation. Diabetes 41:1346-1354
86. Sonnenberg GE, Hoffmann RG, Johnson CP, Kissebah AH 1992 Low- and high-frequency insulin secretion pulses in normal subjects and pancreas transplant recipients: role of extrinsic innervation. J Clin Invest 90:545-553
87. O'Meara NM, Sturis J, Blackman JD, Byrne MM, Jaspan JB, Roland DC, Thistlethwaite JR, Polonsky KS 1993 Oscillatory insulin secretion after pancreas transplant. Diabetes 42:855-861
88. Robertson RP, Diem P, Sutherland DE 1991 Time-related, cross-sectional and prospective follow-up of pancreatic endocrine function after pancreas allograft transplantation in type 1 (insulin-dependent) diabetic patients. Diabetologia 34(Suppl 1):S57-S60
89. Osei K, Cottrell D, Henry ML, Tesi RJ, Ferguson RM, O'Dorisio TM 1992 Minimal model analysis of insulin sensitivity in glucose mediated glucose disposal in type I (insulin dependent) diabetic pancreas allograft recipients. Diabetologia 35:676-680
90. Landgraf R, Nusser J, Riepl RL, Fiedler F, Illner WD, Abendroth D, Land W 1991 Metabolic and hormonal studies of type 1 (insulin-dependent) diabetic patients after successful pancreas and kidney transplantation. Diabetologia 34(Suppl 1):S61-S67
91. Cottrell D, Henry M, O'Dorisio T, Tesi R, Ferguson R, Osei K 1992 Sequential metabolic studies of pancreas allograft function in type 1 diabetic recipients. Diabet Med 9:438-443
92. Elmer DS, Hathaway DK, Bashar Abdulkarim A, Hughes TA, Shokouh-Amiri H, Gaber LW, Gaber AO 1998 Use of glucose disappearance rates (kG) to monitor endocrine function of pancreas allografts. Clin Transplant 12:56-64
93. Ostman J, Bolinder J, Gunnarsson R, Btattstrom C, Tyden G, Wahren J, Groth CG 1989 Effects of pancreas transplantation on metabolic and hormonal profiles in IDDM patients. Diabetes 38(Suppl 1):88-93
94. Christiansen E, Roder M, Tibell A, Hales CN, Madsbad S 1998 Effect of pancreas transplantation and immunosuppression on proinsulin secretion. Diabet Med 15:739-746
95. Babazono T, Teraoka S, Tomonaga O, Iwamoto Y, Omori Y 1998 Circulating proinsulin levels in insulin-dependent diabetic patients after whole pancreas-kidney transplantation. Metabolism 47:1325-1330
96. Weide LG, Stratta RJ, Cushing K, Groggel G 1997 Elevated fasting pro-insulin levels as a marker for impaired function after pancreas transplantation. Transplant Proc 29:678
97. Diem P, Redmon JB, Abid M, Moran A, Sutherland DE, Halter JB, Robertson RP 1990 Glucagon, catecholamine and pancreatic polypeptide secretion in type I diabetic recipients of pancreas allografts. J Clin Invest 86:2008-2113
98. Christiansen E, Tibell A, Volund A, Rasmussen K, Groth GC, Holst JJ, Pedersen O, Christensen NJ, Madsbad S 1996 Pancreatic endocrine function in recipients of segmental and whole pancreas transplantation. J Clin Endocrinol Metab 81:3972-3979
99. Christiansen E, Tibell A, Volund AA, Holst JJ, Rasmussen K, Schaffer L, Madsbad S 1997 Metabolism of oral glucose in pancreas transplant recipients with normal and impaired glucose tolerance. J Clin Endocrinol Metab 82:2299-2307
100. Nauck MA, Busing M, Orskov C, Siegel EG, Talartschik J, Baartz A, Baartz T, Holzer H, Hopt UT, Ebert R, Becker H-D, Creutzfeldt W 1992 Basal and nutrient-stimulated pancreatic and gastrointestinal hormone concentrations in type-1-diabetic patients after successful combined pancreas and kidney transplantation. Clin Invest 70:40-48
101. Barrou Z, Seaquist ER, Robertson RP 1994 Pancreas transplantation in diabetic humans normalizes hepatic glucose production during hypoglycemia. Diabetes 43:661-666
102. Pfeffer F, Nauck MA, Drognitz O, Benz S, von Dobschuetz E, Hopt UT 2003 Postoperative oral glucose tolerance and stimulated insulin secretion: a predictor of endocrine graft function more than 10 years after pancreas-kidney transplantation. Transplantation 76:1427-1431
103. Battezzati A, Benedini S, Caldara R, Calori G, Secchi A, Pozza G, Luzi L 2001 Prediction of the long-term metabolic success of the pancreatic graft function. Transplantation 71:1560-1565
104. Bolinder J, Wahrenberg H, Persson A, Linde B, Tyden G, Grath CG, Ostman J 1991 Effect of pancreas transplantation on glucose counterregulation in insulin-dependent diabetic patients prone to severe hypoglycaemia. J Intern Med 230:527-533
105. Kendall DM, Rooney DP, Smets YF, Salazar Bolding L, Robertson RP 1997 Pancreas transplantation restores epinephrine response and symptom recognition during hypoglycemia in patients with long-standing type I diabetes and autonomic neuropathy. Diabetes 46:249-257
106. Cottrell DA, Henry ML, O'dorisio TM, Tesi R, Ferguson RM, Osei K 1991 Hypoglycemia after successful pancreas transplantation in type I diabetic patients. Diabetes Care 14:1111-1113
107. Larsen JL, Forsman JA, Miller SA, Taylor RJ, Stratta RJ 1994 Symptoms of hypoglycemia are experienced by majority of combined pancreas-kidney transplant recipients but documented hypoglycemia was infrequent. Transplant Proc 26:476-477
108. Redmon JB, Teuscher AU, Robertson RP 1998 Hypoglycemia after pancreas transplantation. Diabetes Care 21:1944-1950
109. Hirshberg B, Trelezky V, Raz I 1998 Hypoglycaemia following pancreatic allograft transplantation. J Intern Med 243:389-393
110. Semakula C, Pambuccian S, Gruessner R, Kendall D, Pittenger G, Vinik A, Seaquist ER 2002 Clinical case seminar: hypoglycemia after pancreas transplantation: association with allograft nesidiodysplasia and expression of islet neogenesis-associated peptide. J Clin Endocrinol Metab 87:3548-3554
111. Gupta V, Wahoff DC, Rooney DP, Poitout V, Sutherland DE, Kendall DM, Robertson RP 1997 The defective glucagon response from transplanted intrahepatic pancreatic islets during hypoglycemia is transplantation site-determined. Diabetes 46:28-33
112. Kendall DM, Teuscher AU, Robertson RP 1997 Defective glucagon secretion during sustained hypoglycemia following successful islet allo- and autotransplantation in humans. Diabetes 46:23-27
113. The Diabetes Control and Complications Trial Research Group 1993 The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986
114. Mauer S, Steffes M, Connett J, Najarian J, Sutherland D, Barbosa J 1983 The development of lesions in the glomerular basement membrane and mesangium after transplantation of normal kidneys to diabetic patients. Diabetes 32:948-952
115. Wilczek H, Jaremko G, Tyden G, Groth C 1995 Evolution of diabetic nephropathy in kidney grafts. Evidence that a simultaneously transplanted pancreas exerts a protective effect. Transplantation 59:51-57
116. LeFrancois N, Petruzzo P, Sepeteanu I, Da Silva M, McGregor B, Dawahra M, Hadj-Aissa A, Dubernard JM, Touraine JL, Martin X 2001 Impact of the functioning pancreas on long-term renal function in pancreas-kidney transplantation. Transplant Proc 33:1690
117. Fioretto P, Mauer SM, Bilous R, Goetz F, Sutherland D, Steffes M 1993 Effects of pancreas transplantation on glomerular structure in insulin-dependent diabetic patients with their own kidneys. Lancet 342:1193-1196
118. Scheider A, Meyer-Schwickerath E, Nusser J, Land W, Landgraf R 1991 Diabetic retinopathy and pancreas transplantation: a 3-year follow-up. Diabetologia 34(Suppl 1):S95-S99
119. Koznarova R, Saudek F, Sosna T, Adamec M, Jedinakova T, Boucek P, Bartos V, Lanska V 2000 Beneficial effect of pancreas and kidney transplantation on advanced diabetic retinopathy. Cell Transplant 2000 9:903-908
120. Landgraf R, Nusser J, Muller W, landgraf-Leurs MM, Thurau S, Ulbig M, Kampik A, Lachenmayr B, Hillebrand G, Schleibner S, Illner W-D, Abendroth D, Land W 1989 Fate of late complications in type I diabetic patients after successful pancreas-kidney transplantation. Diabetes 38(Suppl 1):33-37
121. Ulbig M, Kampik A, Thurau S, Landgraf R, Land W 1991 Long-term follow-up of diabetic retinopathy for up to 71 months after combined renal and pancreatic transplantation. Graefes Arch Clin Exp Ophthalmol 229:242-245
122. Schmidt D, Kirste G, Schrader W 1994 Progressive proliferative diabetic retinopathy after transplantation of the pancreas. A case and a review of the topic. Acta Ophthalmol (Copenh) 72:743-751
123. Sosna T, Saudek F, Dominek Z 1998 Effect of successful combined renal and pancreatic transplantation on diabetic retinopathy. Acta Univ Palacki Olomuc Fac Med 141:75-77
124. Sutherland DE, Dunn DL, Goetz FC, Kennedy W, Ramsay RC, Steffes MW, Mauer SM, Gruessner R, Moudry-Munns KC, Morel P, Viste A, Robertson RP, Najarian JS 1989 A 10-year experience with 290 pancreas transplants at a single institution. Ann Surg 210:274-285; discussion 285-288
125. Petersen MR, Vine AK 1990 Progression of diabetic retinopathy after pancreas transplantation. The University of Michigan Pancreas Transplant Evaluation Committee. Ophthalmology 97:496-500; discussion 501-502
126. French AE, Soldin SJ, Soldin OP, Koren G 2003 Milk transfer and neonatal safety of tacrolimus. Ann Pharmacother 37:815-818
127. Ramsay R, Goetz F, Sutherland DE, Mauer SM, Robison LL, Cantrill HL, Knobloch WH, Najarian JS 1988 Progression of diabetic retinopathy after pancreas transplantation for insulin-dependent diabetes mellitus. N Engl J Med 318:208-214
128. Chow V, Pai R, Chapman J, O'Connell PJ, Allen RD, Mitchell P, Nankivell BJ 1999 Diabetic retinopathy after combined kidney-pancreas retinopathy. Clin Transplant 13:356-362
129. Konigsrainer A, Miller K, Steurer W, Lieselbach G, Aichberger C, Ofner D, Margreiter R 1991 Does pancreas transplantation influence the course of diabetic retinopathy? Diabetologia 34 (Suppl 1):S86-S88
130. Wang Z, Klein R, Moss S, Klein BE, Hoyer C, Burke K, Sollinger HW 1994 The influence of combined kidney-pancreas transplantation on the progression of diabetic retinopathy, a case series. Ophthalmology 101:1071-1076
131. Pearce IA, Ilango B, Sells RA, Wong D 2000 Stabilisation of diabetic retinopathy following simultaneous pancreas and kidney transplant. Br J Ophthalmol 84:736-740
132. Bandello F, Vigano C, Secchi A, Martinenghi S, Caldara R, Di Carlo V, Pozza G, Brancato R 1991 Effect of pancreas transplantation on diabetic retinopathy: a 20 case report. Diabetologia 34 (Suppl 1):S92-S94
133. Giannarelli R, Coppelli A, Sartini MS, Aragona M, Boggi U, Mosca F, Nardi M, Del Prato S, Marchetti P 2002 Early improvement of unstable diabetic retinopathy after solitary pancreas transplantation. Diabetes Care 25:2358-2359
134. Pai RP, Mitchell P, Chow VC, Chapman JR, O'Connell PJ, Allen RD, Nankivell BJ 2000 Posttransplant cataract: lessons from kidney-pancreas transplantation. Transplantation 69:1108-1114
135. Zech JC, Trepsat D, Gain-Gueugnon M, Lefrancois N, Martin X, Dubernard JM 1991 Ophthalmological follow-up of type 1 (insulin-dependent) diabetic patients after kidney and pancreas transplantation. Diabetologia 34 (Suppl 1):S89-S91
136. Kennedy WR, Navarro X, Sutherland DE 1995 Neuropathy profile of diabetic patients in a pancreas transplantation program. Neurology 45:773-780
137. Kennedy WR, Navarro X, Goetz FC, Sutherland DE, Najarian JS 1990 Effects of pancreatic transplantation on diabetic neuropathy. N Engl J Med 322:1031-1037
138. Solders G, Tyden G, Persson A, Groth CG 1992 Improvement of nerve conduction in diabetic neuropathy. A follow-up study 4 yr after combined pancreatic and renal transplantation. Diabetes 41:946-951
139. Muller-Felber W, Landgraf R, Scheuer R, Wagner S, Reimers CD, Nusser J, Abendroth D, Illner WD, Land W 1993 Diabetic neuropathy 3 years after successful pancreas and kidney transplantation. Diabetes 42:1482-1485
140. Navarro X, Sutherland DE, Kennedy WR 1997 Long-term effects of pancreatic transplantation on diabetic neuropathy. Ann Neurol 42:727-736
141. Martinenghi S, Comi G, Galardi G, Di Carlo V, Pozza G, Secchi A 1997 Amelioration of nerve conduction velocity following simultaneous kidney/pancreas transplantation is due to the glycaemic control provided by the pancreas. Diabetologia 40:1110-1112
142. Allen R, Al-Harbi I, Morris J, Clouston PD, O'Connell PJ, Chapman JR, Nankivell BJ 1997 Diabetic neuropathy after pancreas transplantation. Transplantation 63:830-838
143. Dyck PJ, Velosa JA, Pach JM, Sterioff S, Larson TS, Norell JE, O'Brien PC, Dyck PJ 2001 Increased weakness after pancreas and kidney transplantation. Transplantation 72:1403-1408
144. Solders G, Tyden G, Persson A, Groth C-G 1991 Improvement in diabetic neuropathy 4 years after successful pancreatic and renal transplantation. Diabetologia 34 (Suppl 1):S125-S127
145. Maes BD, Vanwalleghem J, Kuypers D, Ghoos Y, Rutgeerts PJ, Vanrenterghem YF 1999 Differences in gastric motor activity in renal transplant recipients treated with FK-506 versus cyclosporine. Transplantation 68:1482-1485
146. Maes BD, Dalle I, Geboes K, Oellench M, Armstrong VW, Evenepoel P, Geypens B, Kuypers D, Shipkova M, Geboes K, Vanrenterghem VF 2003 Erosive enterocolitis in mycophenolate mofetil-treated renal-transplant recipients with
147. Cashion AK, Hathaway DK, Milstead EJ, Reed L, Gaber AO 1999 Changes in patterns of 24-hr heart rate variability after kidney and kidney-pancreas transplant. Transplantation 68:1846-1850
148. Murphy DB, Sutton A, Prescott LF, Murphy MB 1997 A comparison of the effects of tramadol and morphine on gastric emptying in man. Anaesthesia 52:1224-1229
149. Pertwee RG 2001 Carmabinoids and the gastrointestinal tract. Gut 48:859-867
150. Huilgol V, Evans J, Hellman RS, Soergel KH 2002 Acute effect of clonidine on gastric emptying in patients with diabetic gastropathy and controls. Aliment Pharmacol Ther 16:945-950
151. Hathaway DK, Abell T, Cardoso S, Hartwig MS, el Gebely S, Gaber AO 1994 Improvement in autonomic and gastric function following pancreas-kidney versus kidney-alone transplantation and the correlation with quality of life. Transplantation 57:816-822
152. Hartwig MS, Cardoso SS, Hathaway DK, Gaber AO 1994 Reliability and validity of cardiovascular and vasomotor autonomic function tests. Diabetes Care 17:1433-1440
153. Boucek P, Bartos V, Vanek I, Hyza Z, Skibova J 1991 Diabetic autonomic neuropathy after pancreas and kidney transplantation. Diabetologia 34(Suppl 1):S121-S124
154. Boucek P, Saudek F, Adamec M, Janousek L, Koznarova R, Havrdova T, Skibova J 2003 Spectral analysis of heart rate variation following simultaneous pancreas and kidney transplantation. Transplant Proc 35:1494-1498
155. Jonerskog G, Tyden G, Bolinder J, Fagrell B 1991 Skin microvascular reactivity in fingers of diabetic patients after combined and pancreas transplantation. Diabetologia 34(Suppl 1):S135-S137
156. Abendroth D, Schmand J, Landgraf R, Illner W, Land W 1991 Diabetic microangiopathy in type 1 (insulin dependent) diabetic patients after successful pancreatic and kidney or solitary kidney transplantation. Diabetologia 34(Suppl 1):S131-S134
157. Cheung A, Perez R, Chen P 1999 Improvements in diabetic microangiopathy after successful simultaneous pancreas-kidney transplantation: a computer-assisted intravital microscopy study on the conjunctival microcirculation. Transplantation 68:927-932
158. Gfesser M, Nusser J, Muller-Felber W, Abendroth D, Land W, Landgraf R 1993 Cross-sectional study of peripheral microcirculation in diabetic patients with microangiopathy: influence of pancreatic and kidney transplantation. Acta Diabetol 30:79-84
159. Young BA, Marsh CL, Alpers CE, Davis CL 1996 Cyclosporine-associated thrombotic microangiopathy/hemolytic uremic syndrome following kidney and kidney-pancreas transplantation. Am J Kidney Dis 28:561-571
160. Burke GW, Ciancio G, Cirocco R, Markou M, Roth D, Esquenazi V, Tzakis A, Miller J 1998 Tacrolimus-related microangiopathy in kidney and simultaneous pancreas-kidney recipients: evidence of endothelin and cytokine involvement. Transplant Proc 30:661-662
161. Zarifian A, Meleg-Smith S, O'Donovan R, Tesi RJ, Batuman V 1999 Cyclosporine-associated thrombotic microangiopathy in renal allografts. Kidney Int 55:2457-2466
162. Kosch M, Hausberg M, Suwelack B 2003 Studies on effects of calcineurin inhibitor withdrawal on arterial distensibility and endothelial function in renal transplant recipients. Transplantation 76:1516-1519
163. Markowski D, Larsen J, McElligott M, Walter GA, Miller SA, Frisbie K, Stratta RJ 1996 Diet after pancreas transplantation. Diabetes Care 19:735-738
164. Nankivell B, Lau S-G, Chapman J, O'Connell P, Fletcher J, Allen R 2000 Progression of macrovascular disease after transplantation. Transplantation 69:574-581
165. Hughes TA, Gaber AO, Amiri HS, Wang X, Elmer DS, Winsett RP, Hathaway DK, Hughes SM, Ghawji M 1994 Lipoprotein composition in insulin-dependent diabetes mellitus with chronic renal failure: effect of kidney and pancreas transplantation. Metabolism 43:333-347
166. Friemann S, Feuring E, Padberg W, Ernst W 1998 Improvement of nephrotoxicity, hypertension, and lipid metabolism after conversion of kidney transplant recipients from cyclosporine to tacrolimus. Transplant Proc 30:1240-1242
167. Johnson RW, Kreis H, Oberbauer R, Brattstrom C, Claesson K, Eris J 2001 Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure. Transplantation 72:777-786
168. Klein IH, Abrahams A, van Ede T, Hene RJ, Koomans HA, Ligtenberg G 2002 Different effects of tacrolimus and cyclosporine on renal hemodynamics and blood pressure in healthy subjects. Transplantation 73:732-736
169. Elliott M, Kapoor A, Parker M, Kaufman D, Bonow R, Gheorghiade M 2001 Improvement in hypertension in patients with diabetes mellitus after kidney/pancreas transplantation. Circulation 104:563-569
170. Hricik D, Chareandee C, Knauss T, Schulak J 2000 Hypertension after kidney-pancreas transplantation: role of bladder vs enteric pancreatic drainage. Transplantation 70:494-496
171. Henley SA, Akhter J, Stratta RJ, Mack-Shipman LR, Miller SJ, Frisbie K, Taylor R, Erickson JM, Leone JP, Lyden E, Ratanasuwan T, Larsen JL 1999 Lipids increase after solitary pancreas transplantation. Diabetes Care 22:320-327
172. Coppelli A, Giannarelli R, Mariotti R, Rondinini L, Fossati V, Vistoli F, Aragona M, Rizzo G, Boggi U, Mosca F, Del Prato S, Marchetti P 2003 Pancreas transplant alone determines early improvement of cardiovascular risk factors and cardiac function in type 1 diabetic patients. Transplantation 76:974-976
173. Brattstrom C, Wilczek H, Tyden G, Bottiger Y, Sawe J, Groth CG 1998 Hyperlipidemia in renal transplant recipients treated with sirolimus (rapamycin). Transplantation 65:1272-1274
174. van Hooff JP, Squifflet JP, Wlodarczyk Z, Vanrenterghem Y, Paczek L 2003 A prospective randomized multicenter study of tacrolimus in combination with sirolimus in renal-transplant recipients. Transplantation 75:1934-1939
175. Morrisett JD, Abdel-Fattah G, Hoogeveen R, Mitchell E, Ballantyne CM, Pownall HJ, Opekun AR, Jaffe JS, Oppermann S, Kahan BD 2002 Effects of sirolimus on plasma lipids, lipoprotein levels, and fatty acid metabolism in renal transplant patients. J Lipid Res 43:1170-1180
176. Gonwa T, Mendez R, Yang HC, Weinstein S, Jensik S, Steinberg S 2003 Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months. Transplantation 75:1213-1220
177. Chueh SC, Kahan BD 2003 Dyslipidemia in renal transplant recipients treated with a sirolimus and cyclosporine-based immunosuppressive regimen: incidence, risk factors, progression, and prognosis. Transplantation 76:375-382
178. Larsen JL, Stratta RJ, Miller S, Ozaki C, Taylor RJ, Duckworth WD 1992 Lipid status improves following combined pancreas-kidney transplantation. Diabetes Care 15:35-42
179. Hricik DE, Bartucci MR, Mayes JT, Schulak JA 1992 The effects of steroid withdrawal on the lipoprotein profiles of cyclosporine-treated kidney and kidney-pancreas transplant recipients. Transplantation 54:868-871
180. Larsen J, Larson C, Hirst K, Miller SA, Ozaki CF, Taylor RJ, Stratta RJ 1992 Lipid status after combined pancreas-kidney transplantation and kidney transplantation alone in type I diabetes mellitus. Transplantation 54:992-996
181. La Rocca E, Secchi A, Parlavecchia M, Bonfatti D, Ragogna F, Di Carlo V, Pozza G, Ruotolo G 1995 Lipoprotein profile after combined kidney-pancreas transplantation in insulin dependent diabetes mellitus. Transpl Int 8:190-195
182. Foger B, Konigsrainer A, Ritsch A, Lechleitner M, Steuer W, Margreiter R, Patsch JR 1999 Pancreas transplantation modulates reverse cholesterol transport. Transpl Int 12:360-364
183. Araki S-I, Moczulski D, Hanna L, Scott L, Warram J, Krolewski A 2000 ApoE polymorphisms and the development of diabetic nephropathy in type 1 diabetes. Diabetes 49:2190-2195
184. Balakrishnan S, Colling C, Burkman T, Erickson J, Lyden E, Maheshwari H, Mack-Sipman L, Lane J, Larsen J 2002 Apolipoprotein E gene polymorphism alters lipids before pancreas transplantation. Transplantation 74:974-977
185. Woeste G, Wullstein C, Pridohl O, Lubke P, Schwarz R, Kohlhaw K, Bechstein WO 2003 Incidence of minor and major amputations after pancreas/kidney transplantation. Transpl Int 16:128-132
186. Fiorina P, La Rocca E, Astorri E, Lucignani G, Rossetti C, Fazio F, Giudici D, di Carlo V, Cristallo M, Pozza G, Secchi A 2000 Reversal of left ventricular diastolic dysfunction after kidney-pancreas transplantation in type 1 diabetic uremic patients. Diabetes Care 23:1804-1810
187. Fiorina P, La Rocca E, Venturini M, Minicucci F, Fermo I, Paroni R, D'Angelo A, Sblendido M, Di Carlo V, Cristallo M, Del Maschio A, Pozza G, Secchi A 2001 Effects of kidney-pancreas transplantation on atherosclerotic risk factors and endothelial function in patients with uremia and type 1 diabetes. Diabetes 50:496-501
188. Gliedman ML, Tellis VA, Soberman R, Rifkin H, Veith FJ 1978 Long-term effects of pancreatic transplant function in patients with advanced juvenile-onset diabetes. Diabetes Care 1:1-9
189. Morrissey P, Shaffer D, Monaco A, Conway P, Madras P 1997 Peripheral vascular disease after kidney-pancreas transplantation in diabetic patients with end-stage renal disease. Arch Surg 132:358-361
190. Knight RJ, Schanzer H, Guy S, Fishbein T, Burrows L, Miller C 1998 Impact of kidney-pancreas transplantation on the progression of peripheral vascular disease in diabetic patients with end-stage renal disease. Transplant Proc 30:1947-1949
191. Biesenbach G, Margreiter R, Konigsrainer A, Bosmuller C, Janko O, Brucke P, Gross C, Zazgornik J 2000 Comparison of progression of macrovascular diseases after kidney or pancreas and kidney transplantation in diabetic patients with end-stage renal disease. Diabetologia 43:231-234
192. Bruce DS, Newell KA, Josephson MA, Woodle ES, Piper JB, Millis JM, Seaman DS, Carnrike Jr CL, Huss E, Thistlethwaite Jr JR 1996 Long-term outcome of kidney-pancreas transplant recipients with good graft function at one year. Transplantation 62:451-456
193. Nakache R, Tyden G, Groth CG 1989 Quality of life in diabetic patients after combined pancreas-kidney or kidney transplantation. Diabetes 38(Suppl 1):40-42
194. Zehrer CL, Gross CR 1993 Prevalence of "low blood glucose" symptoms and quality of life in pancreas transplant recipients. Clin Transplant 7:312-319
195. Gross C, Zehrer C 1992 Health-related quality of life of outcomes of pancreas transplant recipients. Clin Transplant 6:165
196. Zehrer C, Gross C 1991 Quality of life of pancreas transplant recipients. Diabetologia 34(Suppl 1):S145-S149
197. Milde FK, Hart LK, Zehr PS 1995 Pancreatic transplantation. Impact on the quality of life of diabetic renal transplant recipients. Diabetes Care 18:93-95
198. Kiebert GM, van Oosterhout EC, van Bronswijk H, Lemkes HH, Gooszen HG 1994 Quality of life after combined kidney-pancreas or kidney transplantation in diabetic patients with end-stage renal disease. Clin Transplant 8:239-245
199. Sureshkumar KK, Mubin T, Mikhael N, Kashif MA, Nghiem DD, Marcus RJ 2002 Assessment of quality of life after simultaneous pancreas-kidney transplantation. Am J Kidney Dis 39:1300-1306
200. Gross CR, Limwattananon C, Matthees B, Zehrer JL, Savik K 2000 Impact of transplantation on quality of life in patients with diabetes and renal dysfunction. Transplantation 70:1736-1746
201. Humar A, Khwaja K, Ramcharan T, Asolati M, Kandaswamy R, Gruessner RW, Sutherland DE, Gruessner AC 2003 Chronic rejection: the next major challenge for pancreas transplant recipients. Transplantation 76:918-923
202. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus 2003 Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26:3160-3167
203. Davidson J, Wilkinson A, Dantal J, Dotta F, Haller H, Hernandez D, Kasiske BL, Kiberd B, Krentz A, Legendre C, Marchetti P, Markell M, van der Woude FJ, Wheeler DC 2003 New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003. Transplantation 75(Suppl 10):SS3-SS24
204. Jones Jr JW, Mizrahi SS, Bentley FR 1996 Type II diabetes after combined kidney and pancreas transplantation for type I diabetes mellitus and end-stage renal disease. Clin Transplant 10:574-575
205. Nielsen JH, Mandrup-Poulsen T, Nerup J 1986 Direct effects of cyclosporin A on human pancreatic β-cells. Diabetes 35:1049-1052
206. Draznin B, Metz S, Sussman K, Leitner J 1988 Cyclosporin-induced inhibition of insulin release. Biochem Pharmacol 37:3941-3945
207. Gillison SL, Bartlett ST, Curry DL 1989 Synthesis-secretion coupling of insulin: effect of cyclosporin. Diabetes 38:465-470
208. Basadonna G, Montorsi F, Kakizaki K, Merrell R 1988 Cyclosporin and islet function. Am J Surg 156:191-193
209. Tamura K, Fujimura T, Tsutsumi T, Nakamura K, Ogawa T, Atumaru C, Hirano Y, Ohara K, Ohtsuka K, Shimomura K, Kobayashi M 1995 Transcriptional inhibition of insulin by FK506 and possible involvement of FK506 binding protein-12 in pancreatic β-cell. Transplantation 59:1606-1613
210. Gillison SL, Bartlett ST, Curry DL 1991 Inhibition by cyclosporine of insulin secretion - a β cell-specific alteration of islet tissue function. Transplantation 52:890-895
211. Hirano Y, Mitamura T, Tamura T, Ohara K, Mine Y, Noguchi H 1994 Mechanism of FK506-induced glucose intolerance in rats. J Toxiol Sci 19:61-65
212. Bell E, Cao X, Moibi JA, Greene SR, Young R, Trucco M, Gao Z, Matschinsky FM, Deng S, Markman JF, Naji A, Wolf BA 2003 Rapamycin has a deleterious effect on MIN-6 cells and rat and human islets. Diabetes 52:2731-2739
213. Paty BW, Harmon JS, Marsh CL, Robertson RP 2002 Inhibitory effects of immunosuppressive drugs on insulin secretion from HIT-T15 cells and Wistar rat islets. Transplantation 73:353-357
214. Billaudel B, Sutter BC 1982 Immediate in-vivo effect of corticosterone on glucose-induced insulin secretion in the rat. J Endocrinol 95:315-320
215. Gold G, Qian RL, Grodsky GM 1988 Insulin biosynthesis in HIT cells. Effects of glucose, forskolin, IBMX, and dexamethasone. Diabetes 37:160-165
216. Philippe J, Missotten M 1990 Dexamethasone inhibits insulin biosynthesis by destabilizing insulin messenger ribonucleic acid in hamster insulinoma cells. Endocrinology 127:1640-1645
217. Davani B, Khan A, Hult M, Martensson E, Okret S, Efendic S, Jornvall H, Oppermann UC 2000 Type 1 11β-hydroxysteroid dehydrogenase mediates glucocorticoid activation and insulin release in pancreatic islets. J Biol Chem 275:34841-34844
218. Kneteman NM, Lakey JR, Wagner T, Finegood D 1996 The metabolic impact of rapamycin (sirolimus) in chronic canine islet graft recipients. Transplantation 61:1206-1210
219. Fuhrer DK, Kobayashi M, Jiang H 2001 Insulin release and suppression by tacrolimus, rapamycin and cyclosporin A are through regulation of the ATP-sensitive potassium channel. Diabetes Obes Metab 3:393-402
220. Berg CE, Lavan BE, Rondinone CM 2002 Rapamycin partially prevents insulin resistance induced by chronic insulin treatment. Biochem Biophys Res Commun 293:1021-1027
221. O'Connor JC, Freund GG 2003 Vanadate and rapamycin synergistically enhance insulin-stimulated glucose uptake. Metabolism 52:666-674
222. Lohmann T, Klemm T, Geissler F, Uhlmann D, Ludwig S, Hauss J, Witzigmann H 2002 Islet cell-specific autoantibodies as potential markers for recurrence of autoimmune type 1 diabetes after simultaneous pancreas-kidney transplantation. Transplant Proc 34:2249-2250
223. Bosi E, Braghi S, Maffi P, Scirpoli M, Bertuzzi F, Pozza G, Secchi A, Bonifacio E 2001 Autoantibody response to islet transplantation in type 1 diabetes. Diabetes 50:2464-2471
224. Bosi E, Bottazzo GF, Secchi A, Pozza G, Shattock M, Saunders A, Gelet A, Touraine JL, Traeger J, Dubernard JM 1989 Islet cell autoimmunity in type I diabetic patients after HLA-mismatched pancreas transplantation. Diabetes 38(Suppl 1):82-84
225. Gunnarsson R, Groth CG, Bottazzo GF, Lernmark A 1979 Islet autoantibodies in human pancreatic transplant recipients. Lancet 1:926
226. Lampeter EF, Homberg M, Quabeck K, Schaefer UW, Wernet P, Bertrams J, Grosse-Wilde H, Gries FA, Kolb H 1993 Transfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation. Lancet 341:1243-1244
227. Jaeger C, Brendel MD, Hering BJ, Eckhard M, Bretzel RG 1997 Progressive islet graft failure occurs significantly earlier in autoantibody-positive than in autoantibody-negative IDDM recipients of intrahepatic islet allografts. Diabetes 46:1907-1910
228. Thivolet C, Abou-Amara S, Martin X, Lefrancois N, Petruzzo P, McGregor B, Bosshard S, Dubernard JM 2000 Serological markers of recurrent beta cell destruction in diabetic patients undergoing pancreatic transplantation. Transplantation 69:99-103
229. Jaeger C, Hering BJ, Hatziagelaki E, Federlin K, Bretzel RG 1999 Glutamic acid decarboxylase antibodies are more frequent than islet cell antibodies in islet transplanted IDDM patients and persist or occur despite immunosuppression. J Mol Med 77:45-48
230. Braghi S, Bonifacio E, Secchi A, Di Carlo V, Pozza G, Bosi E 2000 Modulation of humoral islet autoimmunity by pancreas allotransplantation influences allograft outcome in patients with type 1 diabetes. Diabetes 49:218-224
231. Brooks-Worrell BM, Peterson KP, Peterson CM, Palmer JP, Jovanovic L 2000 Reactivation of type 1 diabetes in patients receiving human fetal pancreatic tissue transplants without immunosuppression. Transplantation 69:166-172
232. Da Silva M, Thivolet C, Lefrancois N, Bosshard S, Sepeteanu I, Petruzzo P, Dubernard JM, Martin X 2000 Combined analysis of autoantibodies against β-cells for prediction of pancreas allograft failure. Transplant Proc 32:2773
233. Pileggi A, Ricordi C, Alessiani M, Inverardi L 2001 Factors influencing islet of Langerhans graft function and monitoring. Clin Chim Acta 310:3-16
234. Esmatjes E, Rodriguez-Villar C, Ricart MJ, Casamitjana R, Martorell J, Sabater L, Astudillo E, Fernandez-Cruz L 1998 Recurrence of immunological markers for type 1 (insulin-dependent) diabetes mellitus in immunosuppresssed patients after pancreas transplantation. Transplantation 66:128-131
235. Sundkvist G, Tyden G, Karlsson F, Bolinder J 1998 Islet autoimmunity before and after pancreas transplantation in patients with type 1 diabetes mellitus. Diabetologia 41:1532-1534
236. Moretti ME, Sgro M, Johnson DW, Sauve RS, Woolgar MJ, Taddio A, Verjee Z, Giesbrecht E, Koren G, Ito S 2003 Cyclosporine excretion into breast milk. Transplantation 75:2144-2146
237. Petruzzo P, Andreelli F, McGregor B, Lefrancois N, Dawahra M, Feitosa LC, Dubernard JM, Thivolet C, Martin X 2000 Evidence of recurrent type 1 diabetes following HLA-mismatched pancreas transplantation. Diabete Metab 26:215-218
238. NCEP 2002 Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106:3143-3421
239. Kobashigawa JA, Katznelson S, Laks H, Johnson JA, Yeatman L, Wang XM, Chia D, Terasaki PI, Sabad A, Cogert GA, Trosian K, Hamilton MA, Moriguchi JD, Kawata N, Hage A, Drinkwater DC, Stevenson LW 1995 Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med 333:621-627
240. Katznelson S, Wilkinson AH, Kobashigawa JA, Wang XM, Chia D, Ozawa M, Zhong HP, Hirata M, Cohen AH, Terasaki PI, Danovitch GM 1996 The effect of pravastatin on acute rejection after kidney transplantation - a pilot study. Transplantation 61:1469-1474
241. Martinez-Castelao A, Grinyo J, Gil-Vernet S, Seron D, Castineiras MJ, Ramos R, Alsina J 2002 Lipid-lowering long-term effects of six different statins in hypercholesterolemic renal transplant patients under cyclosporine immunosuppression. Transplant Proc 34:398-400
242. McCune TR, Thacker LR, II, Peters TG, Mulloy L, Rohr MS, Adams PA, Yium J, Light JA, Pruett T, Gaber AO, Selman SH, Jonsson J, Hayes JM, Wright Jr FH, Armata T, Blanton J, Burdick JF 1998 Effects of tacrolimus on hyperlipidemia after successful renal transplantation: a Southeastern Organ Procurement Foundation multicenter clinical study. Transplantation 65:87-92
243. Gruessner RW, Sutherland DE, Parr E, Humar A, Gruessner AC 2001 A prospective, randomized, open-label study of steroid withdrawal in pancreas transplantation-a preliminary report with 6-month follow-up. Transplant Proc 33:1663-1664
244. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G 2000 Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342:145-153
245. Heart Outcomes Prevention Evaluation Study Investigators 2000 Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 355:253-259
246. Ball SG, White WB 2003 Debate: angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers - a gap in evidence-based medicine. Am J Cardiol 91:15G-21G
247. Fishman J, Rubin R 1998 Infection in organ-transplant recipients. N Engl J Med 338:1741-1751
248. Manske CL, Wang Y, Thomas W 1995 Mortality of cadaveric kidney transplantation versus combined kidney-pancreas transplantation in diabetic patients. Lancet 346:1658-1662
249. Stratta RJ, Taylor RJ, Sindhi R, Sudan D, Jerius JT, Gill IS 1996 Analysis of early readmissions after combined pancreas-kidney transplantation. Am J Kidney Dis 28:867-877
250. Pirsch JD, Odorico JS, D'Alessandro AM, Knechtle SJ, Becker BN, Sollinger HW 1998 Posttransplant infection in enteric versus bladder-drained simultaneous pancreas-kidney transplant recipients. Transplantation 66:1746-1750
251. Martinenghi S, Dell'Antonio G, Secchi A, Di Carlo V, Pozza G 1997 Cancer arising after pancreas and/or kidney transplantation in a series of 99 diabetic patients. Diabetes Care 20:272-275
252. Gruessner RW 1997 Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group. Clin Transplant 11:299-312
253. Egidi MF, Trofe J, Stratta RJ, Flax SD, Gaber LW, Shokouh-Amini MH, Jones M, Vera SR, Grewal HP, Alloway RR, Gaber AO 2001 Posttransplant lymphoproliferative disorders: single center experience. Transplant Proc 33:1838-1839
254. Birkeland SA, Hamilton-Dutoit S, Bendtzen K 2003 Long-term follow-up of kidney transplant patients with posttransplant lymphoproliferative disorder: duration of posttransplant lymphoproliferative disorder-induced operational graft tolerance, interleukin-18 course, and results of retransplantation. Transplantation 76:153-158
255. Epstein S, Dissanayake I, Goodman G, Bowman AR, Zhou H, Ma Y, Jee WS 2001 Effect of the interaction of parathyroid hormone and cyclosporine A on bone mineral metabolism in the rat. Calcif Tissue Int 68:240-247
256. Bowman A, Sass D, Dissanayake I, Ma YF, Liang H, Yuan Z, Jee WS, Epstein S 1997 The role of testosterone in cyclosporine-induced osteopenia. J Bone Miner Res 12:607-615
257. Fornoni A, Cornacchia F, Howard G, Roos B, Striker G, Striker L 2001 Cyclosporin A affects extracellular matrix synthesis and degradation by mouse MC3T3-E1 osteoblasts in vitro. Nephrol Dial Transplant 16:500-505
258. Stempfle HU, Werner C, Siebert U, Assum T, Wehr U, Rambeck WA, Meiser B, Theisen K, Gartner R 2002 The role of tacrolimus (FK506)-based immunosuppression on bone mineral density and bone turnover after cardiac transplantation: a prospective, longitudinal, randomized, double-blind trial with calcitriol. Transplantation 73:547-552
259. Weber T, Quarles L 2000 Preventing bone loss after renal transplantation with bisphosphonates: we can, but should we? Kidney Int 57:735-737
260. Chiu M, Sprague S, Bruce D, Woodle E, Thistlethwaite J, Josephson M 1998 Analysis of fracture prevalanece in kidney-pancreas allograft recipients. J Am Soc Nephrol 9:677-683
261. Smets Y, van der Pijl J, de Fijter J, Ringers J, Lemkes H, Handy N 1998 Low bone mass and high incidence of fractures after successful simultaneous pancreas-kidney transplantation. Nephrol Dial Transplant 13:1250-1255
262. Nisbeth U, Lindh E, Ljunghall S, Backman U, Fellstrom B 1999 Increased fracture rate in diabetes mellitus and females after renal transplantation. Transplantation 67:1218-1222
263. Vautour LM, Melton III LJ, Clarke BL, Achenbach SJ, Oberg AL, McCarthy JT 2004 Long-term fracture risk following renal transplantation: a population-based study. Osteoporos Int 15:160-167
264. O'Shaughnessy E, Dahl D, Smith C, Kasiske B 2002 Risk factors for fractures in kidney transplantation. Transplantation 74:362-366
265. Durieux S, Mercadal L, Orcel P, Dao H, Rioux C, Bernard M, Rozenberg S, Barrow B, Bourgeois P, Deray G, Bagnis CI 2002 Bone mineral density and fracture prevalence in long-term kidney graft recipients. Transplantation 74:496-500
266. Jeffery JR, Leslie WD, Karpinski ME, Nickerson PW, Rush DN 2003 Prevalence and treatment of decreased bone density in renal transplant recipients: a randomized prospective trial of calcitriol versus alendronate. Transplantation 76:1498-1502
267. Mack-Shipman L, O'Grady D, Erickson J, Walker CW, Moore TE, Burkman T, Lane JT, Larsen JL 2004 Heel ultrasonography is not a good screening tool for bone loss in kidney and kidney-pancreas transplant recipients. Clin Transplant 18:613-618
268. Cahill BC, O'Rourke MK, Parker S, Stringham JC, Karwande SV, Knecht TP 2001 Prevention of bone loss and fracture after lung transplantation: a pilot study. Transplantation 72:1251-1255
269. Mitchell MJ, Baz MA, Fulton MN, Lisor CF, Braith RW 2003 Resistance training prevents vertebral osteoporosis in lung transplant recipients. Transplantation 76:557-562
270. Stempfle H-U, Werner C, Echtler S, Wehr U, Rambeck WA, Siebert U, Uberfuhr P, Angermann CE, Theisen K, Gartner R 1999 Prevention of osteoporosis after cardiac transplantation. Transplantation 68:523-530
271. Krieg M, Seydoux C, Sandini L, Goy JJ, Berguer DG, Thiebaud D, Burckhardt P 2001 Intravenous pamidronate as treatment for osteoporosis after heart transplantation: a prospective study. Osteoporos Int 12:112-116
272. Van Cleemput J, Daenen W, Geusens P, Dequeker P, Van De Werf F, VanHaecke J 1996 Prevention of bone loss in cardiac transplant recipients. A comparison of biphosphonates and vitamin D. Transplantation 61:1495-1499
273. Bianda T, Linka A, Junga G, Brunner H, Steinert H, Kiowski W, Schmid C 2000 Prevention of osteoporosis in heart transplant recipients: a comparison of calcitriol with calcitonin and pamidronate. Calcif Tissue Int 67:116-121
274. Nincovic M, Love S, Tom B, Bearcroft P, Alexander G, Compston J 2002 Lack of effect of intravenous pamidronate on fracture incidence and bone mineral density after orthotopic liver transplantation. J Hepatol 37:93-100
275. Fan S, Almond M, Ball E, Evans K, Cunningham J 2000 Pamidronate therapy as prevention of bone loss following renal transplantation. Kidney Int 57:684-690
276. Carreau A, Gueugnon J, Benavides J, Vige X 1997 Comparative effects of FK-506, rapamycin and cyclosporin A, on the in vitro differentiation of dorsal root ganglia explants and septal cholinergic neurons. Neuropharmacology 36:1755-1762
277. Brenckmann C, Papioannou A 2001 Bisphosphonates for osteoporosis in people with cystic fibrosis. Cochrane Database Syst Rev 4:CD002010
278. Arlen DJ, Lambert K, Ioannidis G, Adachi JD 2001 Treatment of established bone loss after renal transplantation with etidronate. Transplantation 71:669-673
279. Kovac D, Lindic J, Kandus A, Bren A 2000 Prevention of bone loss with alendronate in kidney transplant recipients. Transplantation 70:1542-1543
280. Henderson K, Eisman J, Keogh A, MacDonald P, Glanville A, Spratt P, Sambrook P 2001 Protective effect of short-term calcitriol or cyclical etidronate on bone loss after cardiac or lung transplantation. J Bone Miner Res 16:565-571
281. Cruz D, Brickel H, Wysolmerski J, Gundberg CG, Simpson CA, Kliger AS, Lorber MI, Basadonna GP, Friedman AL, Insogna KL, Bia MJ 2002 Treatment of osteoporosis and osteopenia in long-term renal transplant patients with alendronate. Am J Transplant 2:62-67
282. Giannini S, Dangel A, Carraro G, Nobile M, Rigotti P, Bonfante L, Marchini F, Zaninotto M, Dalle'Carbonare L, Sartori L, Crepaldi G 2001 Alendronate prevents further bone loss in renal transplant recipients. J Bone Miner Res 16:2111-2117
283. Shane E, Addesso V, Namerow PB, Mcmahon DJ, Lo SH, Staron RB, Zucker M, Pardi S, Maybaum S, Mancini D 2004 Alendronate versus calcitriol for the prevention of bone loss after cardiac transplantation. N Engl J Med 350:767-776
284. Schwarz C, Mitterbauer C, Heinze G, Woloszczuk W, Haas M, Oberbauer R 2004 Nonsustained effect of short-term bisphosphonate therapy on bone turnover three years after renal transplantation. Kidney Int 65:304-309
285. Guichelaar MM, Malinchoc M, Sibonga JD, Clarke BL, Hay JE 2003 Bone histomorphometric changes after liver transplantation for chronic cholestatic liver disease. J Bone Miner Res 18:2190-2199
286. Hay JE, Malinchoc M, Dickson ER 2001 A controlled trial of calcitonin therapy for the prevention of post-liver transplantation atraumatic fractures in patients with primary biliary cirrhosis and primary sclerosing cholangitis. J Hepatol 34:292-298
287. Handelsman DJ, Ralec VL, Tiller DJ, Horvath JS, Turtle JR 1981 Testicular function after renal transplantation. Clin Endocrinol (Oxf) 14:527-538
288. Lim VS, Fang VS 1975 Gonadal dysfunction in uremic men. A study of the hypothalamo-pituitary-testicular axis before and after renal transplantation. Am J Med 58:655-662
289. Smith CR, Butler J, Iggo N, Norman MR 1989 Serum prolactin in uraemia: correlations between bioactivity and activity in two immunoassays. Acta Endocrinol (Copenh) 120:295-300
290. Prem AR, Punekar SV, Kalpana M, Kelkar AR, Acharya VN 1996 Male reproductive function in uraemia: efficacy of haemodialysis and renal transplantation. Br J Urol 78:635-638
291. Saha MT, Saha HH, Niskanen LK, Salmela KT, Pasternack AI 2002 Time course of serum prolactin and sex hormones following successful renal transplantation. Nephron 92:735-737
292. Handelsman DJ, Dong Q 1993 Hypothalamo-pituitary gonadal axis in chronic renal failure. Endocrinol Metab Clin North Am 22:145-161
293. Haberman J, Karwa G, Greenstein SM, Soberman R, Glicklich D, Tellis V, Melman A 1991 Male fertility in cyclosporine-treated renal transplant patients. J Urol 145:294-296
294. Bererhi L, Flamant M, Martinez F, Karras A, Thervet E, Legendre C 2003 Rapamycin-induced oligospermia. Transplantation 76:1885-886
295. Mack-Shipman LR, Ratanasuwan T, Leone JP, Miller SA, Lyden ER, Erickson JM, Larsen JL 2000 Reproductive hormones after pancreas transplantation. Transplantation 70:1180-1183
296. Kim JH, Chun CJ, Kang CM, Kwak JY 1998 Kidney transplantation and menstrual changes. Transplant Proc 30:3057-3059
297. Sawamura M, Takao M, Asano T, Odajima K, Nagakura K, Murai M, Nakamura H 1992 Female gonadal function after renal transplantation. Transplant Proc 24:1573-1575
298. Koutsikos D, Sarandakou A, Agroyannis B, Tzanatos H, Tsoutsos D, Konstadinidou I, Phocas I 1990 The effect of successful renal transplantation on hormonal status of female recipients. Ren Fail 12:125-132
299. Castaneda S, Carmona L, Carvajal I, Arranz R, Diaz A, Garcia-Vadillo A 1997 Reduction of bone mass in women after bone marrow transplantation. Calcif Tissue Int 60:343-347
300. Hart LK, Milde FK, Zehr PS, Cox DM, Tarara DT, Fearing MO 1997 Survey of sexual concerns among organ transplant recipients. J Transpl Coord 7:82-87
301. Armenti VT, Radomski JS, Moritz MJ, Gaughan WJ, Philips LZ, McGrory CH, Coscia LA, National Transplantation Pregnancy Registry 2002 Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation. Clin Transpl 121-130
302. Barrou BM, Gruessner AC, Sutherland DE, Gruessner RW 1998 Pregnancy after pancreas transplantation in the cyclosporine era: report from the International Pancreas Transplant Registry. Transplantation 65:524-527
303. Armenti V, Radomski J, Moritz M, Philips L, McGrory C, Coscia L 2000 Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation. In: Tersaki CA, ed. Clinical transplants 2000. Los Angeles: UCLA Immunogenetics Center; 123-134
304. Armenti VT, Ahlswede KM, Ahlswede BA, Jarrell BE, Moritz MJ, Burke JF 1994 National Transplantation Pregnancy Registry-outcomes of 154 pregnancies in cyclosporine-treated female kidney transplant recipients. Transplantation 57:502-506
305. Burton PB, Yacoub MH, Barton PJ 1998 Rapamycin (sirolimus) inhibits heart cell growth in vitro. Pediatr Cardiol 19:468-470